Biomedical Technology
Graphene for healthcare applications
As the demand for healthcare services continues to increase, so does the demand for novel healthcare solutions. These solutions should be more effective, cost less, prevent and cure disease, and should be equally effective throughout the world. Graphene is paving the way for novel diagnosis and treatments, thanks to its unique properties, such as high surface area, electron mobility, and functionalisation potential; all favourable for biomedical technologies.
For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity makes for effective biosensors. The ability of graphene to be made into scaffolds whilst maintaining the inherent conductivity can be put to use in tissue engineering. New research has shown that graphene can be incorporated with a polymer to make very sensitive electromechanical sensors, and that it can be used to make improved deep brain implants.
The most advanced and promising areas in the biomedical field are currently those where graphene is used in a device configuration. For example, in Point-of-Care or In Vitro diagnostics, graphene can be used as a sensor and be duly functionalized to tune its sensing capabilities. Graphene-based neural interfaces have also demonstrated the possibility to not only detect wavelengths in the brain that cannot be detected with current metal-based technologies, but also to stimulate the tissue, opening up possibilities for new therapies.
Cinzia Spinato, Business Developer for biomedical applications for the Graphene Flagship
Graphene Biomedical Products
From graphene-based retinal implants to robotic prosthetic hands controlled by wearable sensors made by cellulose and graphene composites. Graphene Flagship researchers are using graphene to expand the realm of possibility within the biomedical sector.
The latest on Biomedical Technology
Innovative Materials for EU partnership confirmed
MUNASET: Month 6 meeting took place in Zweibruecken 29 February 2024
Partners from the MUNASET project met to report their progress and set the objectives for upcoming work.
Graphene Flagship and the Advanced Materials 2030 Initiative present partnership proposal
The Graphene Flagship and the Advanced Materials 2030 Initiative organised an online workshop to present the progress of their preparatory work and how the proposed partnership is intended to contribute to the “Advanced Materials for Industrial Leadership” initiative.
The Graphene Flagship: The Voyage Ahead
Over the past decade, the Graphene Flagship created a unique community in Europe – an ecosystem for innovation in graphene and layered materials. Now - with 13 new projects - it’s time to expand and set sail for new horizons.
Global graphene market will continue to grow, researchers find
Meta-market analysis identifies composites, batteries and electronics as major application areas likely to drive the overall development of the graphene market towards mass production.
Ten years of research, innovation and collaboration: the Graphene Flagship and the 2DM community
The Graphene Flagship was funded to ensure that Europe would maintain its lead in graphene research and innovation following the scientific breakthrough of graphene’s isolation at the University of Manchester. The European Commission launched the unprecedented long-term and large-scale Flagship research initiatives to tackle major challenges in science and technology, bringing positive changes that benefit society and the economy and advance European leadership in technology and industry. A decade on, we are proud to say that the Graphene Flagship has delivered on its promise. The clearly achieved objectives within scientific excellence, as well as societal and economic impact are detailed inside these pages.
